NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.
about
Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategiesEmerging data on androgen receptor splice variants in prostate cancerMYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.Targeting MYC in cancer therapy: RNA processing offers new opportunities.Androgen receptor splice variant 7 (AR-V7) and drug efficacy in castration-resistant prostate cancer: Biomarker for treatment selection exclusion or inclusion?Lin28 induces resistance to anti-androgens via promotion of AR splice variant generation.Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting.Androgen receptor variation affects prostate cancer progression and drug resistance.Evaluation of Combined Quantification of PCA3 and AMACR Gene Expression for Molecular Diagnosis of Prostate Cancer in Moroccan Patients by RT-qPCRRNA splicing and splicing regulator changes in prostate cancer pathologyDissecting the roles of the androgen receptor in prostate cancer from molecular perspectives.microRNA-451-modulated hnRNP A1 takes a part in granulocytic differentiation regulation and acute myeloid leukemia.Clinical relevance of androgen receptor alterations in prostate cancer.Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells.The Splicing Factor hnRNPA1 Regulates Alternate Splicing of the MYLK Gene.BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations.Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth.Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer.Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications
P2860
Q26796704-4E41DC6C-C001-4E51-9DCB-F7493A79C982Q28077830-2F0F37BE-50A8-4AC8-B9AC-D185BB304E94Q36535291-A49A0571-AFA6-4FCD-B136-119E0A34BEC1Q36762189-6CE93787-643B-489A-96A8-91AD2887D16BQ37013311-AF5B4D39-43ED-4112-8C6C-D28A6862F1F4Q38808170-650B0EEE-2AB6-4934-9AAE-0E64B94C3816Q38835693-9D581620-6E06-42FE-B7A5-3400B49449A1Q38977288-AAD7DF8C-DB5C-4B45-A593-4473BBE001B4Q38997193-7A1C7E1E-6F69-42DC-9D7C-81118818EC01Q39223617-7F83643D-C850-4662-A4BC-E5CD8FA5A9C0Q39285589-CD421F2F-714F-4427-A64E-ED9AD16652E8Q41548277-27835D0E-0670-42A2-8A95-878C098D2E18Q42377108-D9E3390B-9DBA-43AC-AE70-3225AE2AF69CQ46760444-D7D48A42-58AD-4838-94CA-28827F27597AQ47595502-87484283-F122-409A-AE5E-9CE383BAE381Q47651456-E04A9279-7EC4-4BCB-9945-B0AFA2E6C8B8Q48151505-6EF25D18-38FA-4457-8E4B-339C6774FCF9Q53689786-72EF5D3F-5A7F-49F8-94CE-39F21D51DABFQ53735518-D707106D-984C-4AB9-A03A-C6FC9DFAB894Q57107409-1D080437-AA1D-4068-8BB6-262EAD07E986
P2860
NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
NF-κB2/p52:c-Myc:hnRNPA1 Pathw ...... ensitivity in Prostate Cancer.
@en
type
label
NF-κB2/p52:c-Myc:hnRNPA1 Pathw ...... ensitivity in Prostate Cancer.
@en
prefLabel
NF-κB2/p52:c-Myc:hnRNPA1 Pathw ...... ensitivity in Prostate Cancer.
@en
P2093
P2860
P1476
NF-κB2/p52:c-Myc:hnRNPA1 Pathw ...... ensitivity in Prostate Cancer.
@en
P2093
Allen C Gao
Chengfei Liu
Christopher P Evans
Nagalakshmi Nadiminty
Ramakumar Tummala
P2860
P304
P356
10.1158/1535-7163.MCT-14-1057
P577
2015-06-08T00:00:00Z